A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation

NCT00729768 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: basiliximab
DRUG: efalizumab
DRUG: mycophenolate mofetil
DRUG: corticosteroids
DRUG: cyclosporine

Sponsor

Genentech, Inc.